Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- SEER cancer statistics review, 1975-2015.National Cancer Institute, Bethesda (MD)2018
- Cancer statistics, 2019.CA Cancer J Clin. 2019; 69: 7-34
- Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients.Acta Orthop Scand. 1994; 65: 47-50
- Enzinger and Weiss’s soft tissue tumors, 6th edition.Adv Anat Pathol. 2014; 21: 216
- Sarcomas associated with genetic cancer predisposition syndromes: a review.Oncologist. 2016; 21: 1002-1013
- Monogenic and polygenic determinants of sarcoma risk: an international genetic study.Lancet Oncol. 2016; 17: 1261-1271
- Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the inter-relationships between clinical and morphologic variables.Acta Pathol Microbiol Immunol Scand A. 1984; 92: 363-374
- MRI and CT evaluation of primary bone and soft-tissue tumors.AJR Am J Roentgenol. 1986; 146: 749-756
- Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease.AJR Am J Roentgenol. 1988; 150: 615-620
- The role of magnetic resonance imaging.Acta orthopaedica Scand. 1997; 68: 21-24
- CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: report of the Radiology Diagnostic Oncology Group.Radiology. 1997; 202: 237-246
- FDG PET/CT in initial staging of adult soft-tissue sarcoma.Sarcoma. 2012; 2012: 960194
- Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.Lancet Oncol. 2016; 17: 532-538
- AJCC cancer staging manual.8th edition. Springer, Cham (Switzerland)2017
- Comparative performance of the 7th and 8th editions of the American Joint Committee on cancer staging systems for soft tissue sarcoma of the trunk and extremities.Ann Surg Oncol. 2018; 25: 1126-1132
- A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop Relat Res. 1980; : 106-120
- The role of the pathologist in the management of soft tissue sarcomas.World J Surg. 1988; 12: 326-331
- Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis––the SIN-system.Eur J Cancer. 2003; 39: 1568-1576
- Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery.Semin Oncol. 1997; 24: 540-546
- A comparison of staging systems for localized extremity soft tissue sarcoma.Cancer. 2000; 88: 2721-2730
- Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.J Clin Oncol. 1997; 15: 350-362
- The diagnosis and prognosis of soft tissue tumors.Semin Diagn Pathol. 1986; 3: 240-258
- Comparison between a 2- and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma.J Surg Oncol. 1999; 72: 77-82
- Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry.J Surg Res. 2007; 141: 105-114
- Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size.J Clin Oncol. 2009; 27: 371-376
- AJCC cancer staging handbook.7th edition. Springer-Verlag, New York2010
- Multivariate analysis for histologic prognostic factors in soft tissue sarcomas.Cancer. 1988; 62: 994-998
- Postoperative nomogram for 12-year sarcoma-specific death.J Clin Oncol. 2002; 20: 791-796
- Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.Ann Surg. 2002; 235: 424-434
- Toward better soft tissue sarcoma staging: building on American Joint Committee on cancer staging systems versions 6 and 7.Ann Surg Oncol. 2013; 20: 3377-3383
- The AJCC 8th edition staging system for soft tissue sarcoma of the extremities or trunk: a cohort study of the SEER database.J Natl Compr Canc Netw. 2018; 16: 144-152
- Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.Nat Med. 2010; 16: 781-787
- Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.PLoS One. 2013; 8: e74738
- Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: a systematic review and meta-analysis.Cancer Treat Rev. 2018; 66: 74-81
- Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.Diagn Mol Pathol. 2009; 18: 189-199
- Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.J Clin Oncol. 2010; 28: 2151-2158
- PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a Children's Oncology Group report.Pediatr Blood Cancer. 2013; 60: 1411-1417
- Liposarcoma: multimodality management and future targeted therapies.Surg Oncol Clin N Am. 2016; 25: 761-773
- Overview of multimodality treatment for primary soft tissue sarcoma of the extremities and chest wall.in: Maki R. Pollock R.E. UpToDate. 2018 (Available at:) (Accessed September 1, 2019)
- Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.J Clin Oncol. 1989; 7: 1504-1513
- Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.Eur J Cancer. 2000; 36: 710-716
- Histologic assessment of peritumoral edema in soft tissue sarcoma.Int J Radiat Oncol Biol Phys. 2005; 61: 1439-1445
- Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity.Int J Radiat Oncol Biol Phys. 2012; 84: 1003-1009
- The role of radiation therapy and margin width in localized soft-tissue sarcoma: analysis from the US Sarcoma Collaborative.J Surg Oncol. 2019; 120: 325-331
- Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.Lancet. 2002; 359: 2235-2241
- Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.Int J Radiat Oncol Biol Phys. 2003; 57: 61-70
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.Lancet Oncol. 2011; 12: 127-136
- A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.Radiother Oncol. 2012; 104: 286-293
- Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.Int J Radiat Oncol Biol Phys. 2008; 70: 1124-1129
- Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.Radiat Oncol. 2018; 13: 177
- Influence of radiation treatment technique on outcome and toxicity in anal cancer.J Radiat Oncol. 2017; 6: 413-421
- Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial.J Clin Oncol. 2017; 35: 56-62
- Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.Int J Radiat Oncol Biol Phys. 2012; 84: 1078-1085
- Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma.Cancer. 2013; 119: 1878-1884
- Femoral fracture in primary soft-tissue sarcoma of the thigh and groin treated with intensity-modulated radiation therapy: observed versus expected risk.Ann Surg Oncol. 2019; 26: 1326-1331
- Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh.Cancer. 2010; 116: 1553-1559
- Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.J Clin Oncol. 2014; 32: 3236-3241
- Vortex trial: a randomized controlled multicenter phase 3 trial of volume of postoperative radiation therapy given to adult patients with extremity soft tissue sarcoma (STS).Int J Radiat Oncol Biol Phys. 2016; 96: S1
- Image-guided radiotherapy: has it influenced patient outcomes?.Semin Radiat Oncol. 2012; 22: 50-61
- Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of Radiation Therapy Oncology Group RTOG-0630 Trial.J Clin Oncol. 2015; 33: 2231-2238
- Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.Ann Oncol. 2014; 25: 2425-2432
- Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.Int J Radiat Oncol Biol Phys. 2003; 56: 1117-1127
- Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.Cancer. 2012; 118: 3758-3765
- Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons.Ann Surg. 1987; 205: 349-359
- Influence of biologic factors and anatomic site in completely resected liposarcoma.J Clin Oncol. 2000; 18: 1637-1643
- Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.Ann Surg. 2009; 250: 970-976
- Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.J Surg Res. 2012; 172: 123-130
- Prognosis for primary retroperitoneal sarcoma survivors.Cancer. 2012; 118: 3321-3329
- Outcome and prognosis in retroperitoneal soft tissue sarcoma.Int J Radiat Oncol Biol Phys. 1994; 29: 1005-1010
- Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.Ann Surg. 1998; 228: 355-365
- Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.J Clin Oncol. 1997; 15: 2832-2839
- Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study.Ann Surg. 2015; 262: 156-162
- Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.Lancet Oncol. 2016; 17: 966-975
- Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.Cancer. 2006; 107: 371-379
- Radiation therapy for control of soft-tissue sarcomas resected with positive margins.Int J Radiat Oncol Biol Phys. 2007; 67: 1460-1469
- Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.Int J Radiat Oncol Biol Phys. 2001; 50: 127-131
- Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.Adv Radiat Oncol. 2017; 2: 85-93
- Proton or Photon RT for Retroperitoneal Sarcomas.(Available at:) (Accessed September 1, 2019)
Article info
Publication history
Published online: October 28, 2019
Footnotes
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
